These effects were observed in different <i>in vivo</i> models of breast cancer (<i>e.g.</i>, estrogen receptor-positive, triple-negative, chemically induced) showing better outcomes when compared to treatments with free curcumin or negative controls. This evidence concerns the gene ESR1 and breast carcinoma.